Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.46% |
| 2 | Technology | 18.58% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORGN
2201
DELISTED
Origin Materials
ORGN
| $1.56M | ﹤0.01% |
10,066
+7,999
| +387% | +$1.42M |
|
2202
ADMA Biologics
ADMA
$2.12B
| $1.55M | ﹤0.01% |
638,400
-87,100
| -12% | -$209K |
|
2203
Middleby
MIDD
$5.33B
| $1.55M | ﹤0.01% |
12,100
-34,500
| -74% | -$4.84M |
|
|
ARVL
2204
DELISTED
Arrival Ordinary Shares
ARVL
| $1.55M | ﹤0.01% |
38,428
-37,560
| -49% | -$2.47M |
|
2205
Data I/O
DAIO
$32.9M
| $1.55M | ﹤0.01% |
555,443
-27,900
| -5% | -$89.6K |
|
2206
Sypris Solutions
SYPR
$47.4M
| $1.55M | ﹤0.01% |
833,029
-61,503
| -7% | -$124K |
|
2207
Vanguard Morningstar Value ETF
VTV
$194B
| $1.54M | ﹤0.01% |
+12,500
| New | +$1.69M |
|
2208
AerSale
ASLE
$280M
| $1.54M | ﹤0.01% |
83,200
+14,500
| +21% | +$268K |
|
2209
Theravance Biopharma
TBPH
$881M
| $1.54M | ﹤0.01% |
+152,177
| New | +$1.43M |
|
2210
Schwab International Equity ETF
SCHF
$69.4B
| $1.54M | ﹤0.01% |
109,600
-184,200
| -63% | -$2.89M |
|
|
GBIO
2211
DELISTED
Generation Bio
GBIO
| $1.54M | ﹤0.01% |
29,020
+307
| +1% | +$19.2K |
|
2212
Rigel Pharmaceuticals
RIGL
$795M
| $1.54M | ﹤0.01% |
130,523
+94,073
| +258% | +$1.27M |
|
|
TRIB
2213
Trinity Biotech
TRIB
$7.88M
| $1.54M | ﹤0.01% |
9,588
-434
| -4% | -$83.9K |
|
2214
Boot Barn
BOOT
$4.95B
| $1.54M | ﹤0.01% |
26,300
-300,300
| -92% | -$20.1M |
|
|
SVA
2215
DELISTED
Sinovac Biotech, Ltd
SVA
| $1.54M | ﹤0.01% |
2,375,841
| – | – |
|
2216
OP Bancorp
OPBK
$233M
| $1.53M | ﹤0.01% |
137,895
-42,905
| -24% | -$493K |
|
2217
PC Connection
CNXN
$2.05B
| $1.53M | ﹤0.01% |
33,979
+6,324
| +23% | +$298K |
|
2218
Walker & Dunlop
WD
$1.46B
| $1.53M | ﹤0.01% |
18,300
+100
| +0.5% | +$10.2K |
|
|
NEXN
2219
Nexxen International
NEXN
$583M
| $1.53M | ﹤0.01% |
220,800
-44,400
| -17% | -$391K |
|
2220
Ecovyst
ECVT
$1.14B
| $1.53M | ﹤0.01% |
181,100
+79,900
| +79% | +$760K |
|
2221
Intapp
INTA
$3.07B
| $1.53M | ﹤0.01% |
81,800
+12,407
| +18% | +$195K |
|
2222
Aemetis
AMTX
$128M
| $1.52M | ﹤0.01% |
249,215
-158,556
| -39% | -$1.21M |
|
2223
Pitney Bowes
PBI
$2.25B
| $1.52M | ﹤0.01% |
653,871
-721,800
| -52% | -$2.32M |
|
2224
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $1.52M | ﹤0.01% |
60,100
+34,800
| +138% | +$953K |
|
2225
Genius Sports
GENI
$2.33B
| $1.52M | ﹤0.01% |
414,700
-423,300
| -51% | -$1.52M |
|
Similar funds
Jim Simons's Q3 2022 Portfolio in Review
As of Q3 2022, Jim Simons held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $8.71B in Q3 2022, closing 638 positions and reducing 2,163 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Alphabet (Google) Class A worth $498M.
- Jim Simons's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Jim Simons added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Jim Simons's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Jim Simons fully exited Shopify in Q3 2022, selling an estimated $439M.
- Jim Simons's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Jim Simons opened 441 new positions and closed 638 in Q3 2022.
- Jim Simons's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.